Neofect Co.Ltd (290660) - Total Assets
Based on the latest financial reports, Neofect Co.Ltd (290660) holds total assets worth ₩69.30 Billion KRW (≈ $46.97 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 290660 book value for net asset value and shareholders' equity analysis.
Neofect Co.Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Neofect Co.Ltd's total assets have evolved over time, based on quarterly financial data.
Neofect Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Neofect Co.Ltd's total assets of ₩69.30 Billion consist of 56.4% current assets and 43.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩22.09 Billion | 30.5% |
| Accounts Receivable | ₩2.49 Billion | 3.4% |
| Inventory | ₩3.31 Billion | 4.6% |
| Property, Plant & Equipment | ₩22.58 Billion | 31.2% |
| Intangible Assets | ₩318.73 Million | 0.4% |
| Goodwill | ₩1.24 Billion | 1.7% |
Asset Composition Trend (2016–2024)
This chart illustrates how Neofect Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 290660 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Neofect Co.Ltd's current assets represent 56.4% of total assets in 2024, a decrease from 80.0% in 2016.
- Cash Position: Cash and equivalents constituted 30.5% of total assets in 2024, up from 18.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 15.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 31.2% of total assets.
Neofect Co.Ltd Competitors by Total Assets
Key competitors of Neofect Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Neofect Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 1.39 | 0.88 |
| Quick Ratio | 0.87 | 1.24 | 0.73 |
| Cash Ratio | 0.00 | 0.74 | 0.00 |
| Working Capital | ₩-847.20 Million | ₩9.94 Billion | ₩-3.00 Billion |
Neofect Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Neofect Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | ₩72.36 Billion |
| Market Capitalization | $39.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Neofect Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Neofect Co.Ltd's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Neofect Co.Ltd (2016–2024)
The table below shows the annual total assets of Neofect Co.Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩72.36 Billion ≈ $49.04 Million |
+0.91% |
| 2023-12-31 | ₩71.71 Billion ≈ $48.60 Million |
+42.36% |
| 2022-12-31 | ₩50.37 Billion ≈ $34.14 Million |
-4.13% |
| 2021-12-31 | ₩52.54 Billion ≈ $35.61 Million |
-9.27% |
| 2020-12-31 | ₩57.91 Billion ≈ $39.24 Million |
+23.16% |
| 2019-12-31 | ₩47.02 Billion ≈ $31.86 Million |
+30.89% |
| 2018-12-31 | ₩35.92 Billion ≈ $24.34 Million |
+251.90% |
| 2017-12-31 | ₩10.21 Billion ≈ $6.92 Million |
+28.65% |
| 2016-12-31 | ₩7.93 Billion ≈ $5.38 Million |
-- |
About Neofect Co.Ltd
Neofect Co., Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech me… Read more